Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Multidimensional Assessment of Quality of Life, Social and Professional Life and Care Utilization in Patients With Diffuse Large Cell B-cell Lymphoma Treated With CAR-T Cells
ClinicalTrials.gov study NCT05532761. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma
ClinicalTrials.gov study NCT06079164. IPD Sharing: NO. Countries: 3. Publications: 0.
Study to Evaluate Tolerability of Iberdomide (CC-220) in Combination With Polatuzumab Vedotin Plus Rituximab or Tafasitamab or Rituximab Plus Chemotherapy in B-cell Lymphoma
ClinicalTrials.gov study NCT04882163. IPD Sharing: YES. Countries: 8. Publications: 0.
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
ClinicalTrials.gov study NCT06542250. IPD Sharing: YES. Countries: 10. Publications: 0.
Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT02810223. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT05164042. IPD Sharing: NO. Countries: 1. Publications: 0.
Mitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT05875428. IPD Sharing: NO. Countries: 1. Publications: 0.
Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT03656835. IPD Sharing: NO. Countries: 1. Publications: 0.
Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory B Cell Lymphoma
ClinicalTrials.gov study NCT04715217. IPD Sharing: YES. Countries: 1. Publications: 0.
Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT06249191. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)
ClinicalTrials.gov study NCT04034446. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Patients With Relapsed/Refractory Aggressive B Cell Lymphoma
ClinicalTrials.gov study NCT05464329. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy Study of BAFF-R CAR-T Cells in Adult Subjects With CD19-Negative Relapsed or Refractory B-Cell Lymphoma
ClinicalTrials.gov study NCT07369492. IPD Sharing: NO. Countries: 1. Publications: 0.
A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06464185. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Clinical Activity of ThisCART22 in Patients With r/r Non-Hodgkin's B Cell Lymphoma
ClinicalTrials.gov study NCT05106946. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multiple Fields Radiotherapy Versus Intravenous Rituximab in the Treatment of Indolent Cutaneous Lymphomas B-cell With Multiple or Recurrent Lesions
ClinicalTrials.gov study NCT02867553. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies
ClinicalTrials.gov study NCT04684472. IPD Sharing: NO. Countries: 1. Publications: 0.
CAR20.19.22 T-cells in Relapsed, Refractory B-cell Malignancies
ClinicalTrials.gov study NCT05094206. IPD Sharing: NO. Countries: 1. Publications: 0.
Purify Antigen-specific B Cells From Patients With Rheumatoid Arthritis
ClinicalTrials.gov study NCT05203952. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Anti-CD19 Universal CAR-NK Cells Therapy Combined With HSCT for B Cell Hematologic Malignancies
ClinicalTrials.gov study NCT05570188. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.